Literature DB >> 15481217

How should general practitioners investigate suspected urinary tract infection? Variations in laboratory-confirmed bacteriuria in South West England.

C A M McNulty1, J Bowen, G Clark, A Charlett, K Cartwright.   

Abstract

We analysed by age and sex the inter-laboratory variation in submission rates and positivity rates of urine samples from primary care that were submitted to seven microbiology laboratories within the South West of England. There was an almost twofold difference between the lowest and highest submission and positivity rates across all sex and age groups. This could not be accounted for by differences in population, age mix or numbers of nursing home beds. Increased submission in children will increase diagnosis of urinary tract infection (UTI). In contrast, over-investigation in other age groups increases laboratory and primary care costs and, in the asymptomatic elderly, may lead to unnecessary antibiotic treatment. Continued education is needed in primary care to improve the management of urinary symptoms. Laboratory-based studies of UTI are likely to underestimate the true incidence of this infection substantially. Standardised protocols for urine specimen submission are essential for practices and laboratories participating in surveillance of UTI and antibiotic resistance. In our discussion we offer seven recommendations for improving UTI investigation in general practice.

Entities:  

Mesh:

Year:  2004        PMID: 15481217

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  9 in total

Review 1.  Best practice in primary care pathology: review 2.

Authors:  W S Smellie; J O Forth; C A M McNulty; L Hirschowitz; D Lilic; R Gosling; D Bareford; E Logan; K G Kerr; G P Spickett; J Hoffman; A Galloway; C A Bloxham
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

2.  Microbial evaluation and public health implications of urine as alternative therapy in clinical pediatric cases: health implication of urine therapy.

Authors:  Adenike Adedayo O Ogunshe; Abosede Oyeyemi Fawole; Victoria Abosede Ajayi
Journal:  Pan Afr Med J       Date:  2010-05-25

3.  Problems of basing patient recruitment for primary care studies on routine laboratory submissions.

Authors:  Cliodna McNulty; Michael Thomas; Rhiannon John; Andrew Lovering; Deirdre Lewis; Alasdair MacGowan
Journal:  J Clin Pathol       Date:  2007-03-02       Impact factor: 3.411

4.  Escherichia coli Isolated from Urinary Tract Infections of Lebanese Patients between 2000 and 2009: Epidemiology and Profiles of Resistance.

Authors:  Ziad Daoud; Claude Afif
Journal:  Chemother Res Pract       Date:  2011-10-12

Review 5.  Does clinical examination aid in the diagnosis of urinary tract infections in women? A systematic review and meta-analysis.

Authors:  David Medina-Bombardó; Antoni Jover-Palmer
Journal:  BMC Fam Pract       Date:  2011-10-10       Impact factor: 2.497

6.  Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.

Authors:  Mohammed Akram; Mohammed Shahid; Asad U Khan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2007-03-23       Impact factor: 3.944

7.  Do English NHS Microbiology laboratories offer adequate services for the diagnosis of UTI in children? Healthcare Quality Improvement Partnership (HQIP) Audit of Standard Operational Procedures.

Authors:  Cliodna A M McNulty; Neville Q Verlander; Philippa C L Moore; James Larcombe; Jan Dudley; Jaydip Banerjee; Lyda Jadresic
Journal:  J Med Microbiol       Date:  2015-07-17       Impact factor: 2.472

8.  The state of play in the battle against antimicrobial resistance: a general practitioner perspective.

Authors:  Douglas M Fleming
Journal:  J Antimicrob Chemother       Date:  2007-08       Impact factor: 5.790

9.  Use of antimicrobial resistance information and prescribing guidance for management of urinary tract infections: survey of general practitioners in the West Midlands.

Authors:  Dean Ironmonger; Obaghe Edeghere; Savita Gossain; Peter M Hawkey
Journal:  BMC Infect Dis       Date:  2016-05-24       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.